Patent ID: 6730329
Filing Date: 2004-05-04
Classification: A61K,A61P,Y02A,Y10S

Abstract:
A method of treating lesionous symptoms of a viral infection, comprising:applying an effective amount of a zinc containing composition to the lesions, the zinc containing composition comprising about 0.005% by weight or more and about 20% by weight or less of at least one zinc compound, about 0.001% by weight or more and about 20% by weight or less of at least one phenolic antioxidant selected from the group consisting of a butylated hydroxytoluene, 2(3)-tert-butyl-4-methoxyphenol, 2,6-di-tert-butyl-4-cumylphenol, 2,6-di-tert-butyl-4-nonylphenol, 2,6-dicumylphenol, 2,6-di-tert-butyl-4-isooctylphenol, and 4,4â€²-methylene-bis(2,6-di-tert-butylphenol), and a pharmaceutically acceptable adjuvant.